LIFE SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=19小时前, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了，正常吗，一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省)]

19小时前 ms4000000067455992 来自重庆

偏重的研究方向：肿瘤学
经验分享：刚投稿，希望能在5月前接到ur

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=19小时前, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了，正常吗，一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省)]

2024-04-06 ms1000000596177006 来自山东省

请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况

6 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=19小时前, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了，正常吗，一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省)]

2024-03-29 ms3000000983513178 来自湖北省

不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。

3 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=19小时前, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了，正常吗，一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省)]

2024-01-30 1489114dm38(暂无昵称) 来自四川省

偏重的研究方向：肿瘤学
经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿

27 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=19小时前, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了，正常吗，一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省)]

2024-02-26 侍郎来自安徽省

请问大家life sciences这个杂志必须要三次重复的WB图吗？

14 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=19小时前, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了，正常吗，一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省)]

2024-02-20 ms4000000100009364 来自重庆

2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗

24 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=19小时前, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了，正常吗，一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省)]

2024-02-02 ms9000001986512880 来自河北省

with editor 4天了，正常吗，一般不是with editor两天就给结果了

18 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=19小时前, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了，正常吗，一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省)]

2024-02-19 Rambo 来自北京

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：中药提取物
经验分享：2月16号投稿
2月18号Decision in Process

16 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=19小时前, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了，正常吗，一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省)]

2024-02-26 ms4000000667943195 来自山东省

请问这个杂志审稿费多少啊

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2198948, encodeId=73e62198948ec, content=偏重的研究方向：肿瘤学 经验分享：刚投稿，希望能在5月前接到ur, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d9e8506295, createdName=ms4000000067455992, createdTime=Wed Apr 17 13:37:36 CST 2024, time=19小时前, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2197119, encodeId=5af5219e1197b, content=请问大修under review 3天后变成requird reviews completed，过了两天又under review了是啥情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edd58743851, createdName=ms1000000596177006, createdTime=Sat Apr 06 09:43:40 CST 2024, time=2024-04-06, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2195988, encodeId=5914219598801, content=不像杂志介绍这么快啊，都投稿10天了，还是submitted to journal，有类似情况的小伙伴吗，多来分享经验。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9346572823, createdName=ms3000000983513178, createdTime=Fri Mar 29 08:13:25 CST 2024, time=2024-03-29, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2184806, encodeId=42c82184806ad, content=偏重的研究方向：肿瘤学 经验分享：1.14头稿，1.28 with editor，1.29 under review，4个审稿人接受审稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Tue Jan 30 13:12:56 CST 2024, time=2024-01-30, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2189440, encodeId=b75a2189440cf, content=请问大家life sciences这个杂志必须要三次重复的WB图吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/08/7b0b243cae3335c9a6478c93a5383785.jpg, createdBy=77375316817, createdName=侍郎, createdTime=Mon Feb 26 12:09:33 CST 2024, time=2024-02-26, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2188332, encodeId=ca7f21883325c, content=2月4号投稿，2月4号with editor,一直with editor到20号了，16天了还在with editor,邮件问了说是编辑还在审，要审查这么久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ce38268346, createdName=ms4000000100009364, createdTime=Tue Feb 20 16:20:17 CST 2024, time=2024-02-20, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2185363, encodeId=69d12185363d0, content=with editor 4天了，正常吗，一般不是with editor两天就给结果了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=42998756782, createdName=ms9000001986512880, createdTime=Fri Feb 02 08:35:56 CST 2024, time=2024-02-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2188154, encodeId=20a1218815420, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：中药提取物 经验分享：2月16号投稿 2月18号Decision in Process, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f3f1626582, createdName=Rambo, createdTime=Mon Feb 19 14:27:19 CST 2024, time=2024-02-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2189501, encodeId=9ed6218950165, content=请问这个杂志审稿费多少啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a2c59185992, createdName=ms4000000667943195, createdTime=Mon Feb 26 19:35:59 CST 2024, time=2024-02-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2178876, encodeId=dc5d21e887669, content=偏重的研究方向：细胞生物学 经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e84d2996039, createdName=594624370, createdTime=Tue Jan 02 22:28:19 CST 2024, time=2024-01-02, status=1, ipAttribution=四川省)]

2024-01-02 594624370 来自四川省

偏重的研究方向：细胞生物学
经验分享：2023.12.27投稿，现在都还是submitted to journal😂😂

21 11

展开11条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务